1. Home
  2. AXTI vs ONCY Comparison

AXTI vs ONCY Comparison

Compare AXTI & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXTI
  • ONCY
  • Stock Information
  • Founded
  • AXTI 1986
  • ONCY 1998
  • Country
  • AXTI United States
  • ONCY Canada
  • Employees
  • AXTI N/A
  • ONCY N/A
  • Industry
  • AXTI Semiconductors
  • ONCY Pharmaceuticals and Biotechnology
  • Sector
  • AXTI Technology
  • ONCY Health Care
  • Exchange
  • AXTI Nasdaq
  • ONCY Nasdaq
  • Market Cap
  • AXTI 94.4M
  • ONCY 89.7M
  • IPO Year
  • AXTI 1998
  • ONCY 1999
  • Fundamental
  • Price
  • AXTI $5.31
  • ONCY $1.36
  • Analyst Decision
  • AXTI Strong Buy
  • ONCY Strong Buy
  • Analyst Count
  • AXTI 4
  • ONCY 5
  • Target Price
  • AXTI $4.60
  • ONCY $5.00
  • AVG Volume (30 Days)
  • AXTI 1.9M
  • ONCY 1.0M
  • Earning Date
  • AXTI 10-30-2025
  • ONCY 11-11-2025
  • Dividend Yield
  • AXTI N/A
  • ONCY N/A
  • EPS Growth
  • AXTI N/A
  • ONCY N/A
  • EPS
  • AXTI N/A
  • ONCY N/A
  • Revenue
  • AXTI $86,080,000.00
  • ONCY N/A
  • Revenue This Year
  • AXTI N/A
  • ONCY N/A
  • Revenue Next Year
  • AXTI $29.24
  • ONCY N/A
  • P/E Ratio
  • AXTI N/A
  • ONCY N/A
  • Revenue Growth
  • AXTI N/A
  • ONCY N/A
  • 52 Week Low
  • AXTI $1.13
  • ONCY $0.33
  • 52 Week High
  • AXTI $5.67
  • ONCY $1.53
  • Technical
  • Relative Strength Index (RSI)
  • AXTI 69.71
  • ONCY 60.09
  • Support Level
  • AXTI $4.37
  • ONCY $1.20
  • Resistance Level
  • AXTI $5.48
  • ONCY $1.47
  • Average True Range (ATR)
  • AXTI 0.48
  • ONCY 0.07
  • MACD
  • AXTI 0.03
  • ONCY -0.00
  • Stochastic Oscillator
  • AXTI 80.83
  • ONCY 58.06

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: